Expanded Recall Announced for Ibuprofen Oral Suspension Drops

Share this content:
Expanded Recall Announced for Ibuprofen Oral Suspension Drops
Expanded Recall Announced for Ibuprofen Oral Suspension Drops

WEDNESDAY, Jan. 30, 2019 (HealthDay News) -- An expanded recall of ibuprofen oral suspension drops that may contain higher-than-specified levels of ibuprofen that could harm infants' kidneys has been announced by Tris Pharma, Inc.

The original recall last November was for three lots of ibuprofen oral suspension drops, USP, 50 mg per 1.25 mL. The expanded recall adds three more lots. The products -- packaged in 0.5-oz and 1-oz bottles -- were sold under different names at various pharmacies: Equate at Wal-Mart, CVS Health at CVS, and Family Wellness at Family Dollar.

"Infants already susceptible to the adverse effects of ibuprofen may be at a slightly higher risk if they receive medication from an impacted bottle. There is a remote probability that infants, who may be more susceptible to a higher potency level of drug, may be more vulnerable to permanent nonsteroidal anti-inflammatory drug-associated (kidney) injury," according to a Tris Pharma news release. "Some units from these six lots have been found to contain Ibuprofen as high as 10 percent above the specified limit. Studies have shown that safety issues or toxicity is generally accepted to be a concern in infants at doses in excess of 700 percent of the recommended dose. To date, no serious adverse events have been reported related to this recall."

For more information about the recall, health care providers and consumers can call Tris Pharma at 732-940-0358.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Head Says Feds May Intervene to Cut Vaccine Exemptions

FDA Head Says Feds May Intervene to Cut ...

If states do not change lax vaccine laws, federal authorities may be forced to take action

New Kaiser Permanente Medical School Plans to Waive Tuition

New Kaiser Permanente Medical School Plans to Waive ...

School will waive all tuition for the full four years of school for its first five classes

Experimental Test May Quickly Diagnose Sepsis

Experimental Test May Quickly Diagnose Sepsis

Microelectrode device analyzes a patient's blood, provides results in as quickly as 2.5 minutes

is free, fast, and customized just for you!




Already a member?

Sign In Now »